• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤性骨软化症诊断历程

Diagnostic Journey in the Recognition of Oncogenic Osteomalacia.

作者信息

Nagelberg Steven B, Biscoveanu Mihaela, Bix Barbara, Andrews Carrie, Prasad Srinivas

机构信息

Northeast Endocrine Metabolic Associates of Thomas Jefferson University, Philadelphia, PA.

Holland Medical Associates, Feasterville, PA.

出版信息

JCEM Case Rep. 2025 Sep 1;3(10):luaf179. doi: 10.1210/jcemcr/luaf179. eCollection 2025 Oct.

DOI:10.1210/jcemcr/luaf179
PMID:40900910
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12399365/
Abstract

A 73-year-old woman with a remote history of successfully treated primary hyperparathyroidism was referred to our office because of multiple skeletal fractures and proximal muscle weakness. Prior laboratory evaluation demonstrated hypocalcemia, vitamin D deficiency, elevated PTH, and elevated alkaline phosphatase. Updated evaluation in our clinic additionally showed hypophosphatemia prompting measurement of serum fibroblast growth factor 23 (FGF23). FGF23 proved to be markedly elevated prompting consideration of tumor-induced osteomalacia. Positron emission tomography with Cu-64 oxodotreotide revealed an enhancing focus in the left thoracic spine that was confirmed on magnetic resonance imaging to be a 1.5-cm extradural mass. The patient underwent surgical resection of the mass by the neurosurgery spine service. Pathologic analysis demonstrated a 2.4-cm mesenchymal tumor; mRNA in situ hybridization was positive for FGF23. Laboratory studies 12 weeks postoperatively showed near normalization of the serum FGF23 as well as improvement in her other metabolic abnormalities and clinical symptomatology. This case exemplifies the necessity of measurement of serum inorganic phosphate and a high level of suspicion for hypophosphatemic osteomalacia in patients with numerous fractures beyond that expected for their degree of osteoporosis.

摘要

一名有原发性甲状旁腺功能亢进症成功治疗史的73岁女性,因多处骨骼骨折和近端肌肉无力前来我处就诊。之前的实验室检查显示低钙血症、维生素D缺乏、甲状旁腺激素升高以及碱性磷酸酶升高。我们诊所的最新评估还显示低磷血症,促使检测血清成纤维细胞生长因子23(FGF23)。结果显示FGF23显著升高,提示考虑肿瘤诱导的骨软化症。用Cu-64奥曲肽进行正电子发射断层扫描显示左胸椎有一个强化灶,磁共振成像证实为一个1.5厘米的硬膜外肿块。患者接受了神经外科脊柱团队对该肿块的手术切除。病理分析显示为一个2.4厘米的间叶性肿瘤;FGF23的mRNA原位杂交呈阳性。术后12周的实验室检查显示血清FGF23接近正常,其他代谢异常和临床症状也有所改善。该病例体现了对于骨折数量超过预期骨质疏松程度的患者,检测血清无机磷以及高度怀疑低磷性骨软化症的必要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59de/12399365/cf2218c466e3/luaf179f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59de/12399365/cf2218c466e3/luaf179f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59de/12399365/cf2218c466e3/luaf179f1.jpg

相似文献

1
Diagnostic Journey in the Recognition of Oncogenic Osteomalacia.肿瘤性骨软化症诊断历程
JCEM Case Rep. 2025 Sep 1;3(10):luaf179. doi: 10.1210/jcemcr/luaf179. eCollection 2025 Oct.
2
Familial cases with adult-onset FGF23-related hypophosphatemic osteomalacia -A PHEX 3'-UTR change as a possible cause.家族性成发病例伴有 FGF23 相关低血磷性骨软化症-作为可能原因的 PHEX 3'-UTR 改变。
Bone. 2024 May;182:117057. doi: 10.1016/j.bone.2024.117057. Epub 2024 Feb 25.
3
Real-World Effectiveness of Burosumab Versus Oral Phosphate and Active Vitamin D in Adults With X-Linked Hypophosphatemia.布罗索尤单抗与口服磷酸盐和活性维生素D治疗成人X连锁低磷血症的真实世界疗效比较
J Bone Miner Res. 2025 May 2. doi: 10.1093/jbmr/zjaf063.
4
X-Linked HypophosphatemiaX连锁低磷血症
5
Failure of femoral internal fixation device secondary to phosphaturic mesenchymal tumor: a case report and literature review.继发于磷尿性间叶肿瘤的股骨内固定装置失效:1例病例报告及文献复习
BMC Musculoskelet Disord. 2025 Sep 1;26(1):831. doi: 10.1186/s12891-025-09066-0.
6
Oncogenic rickets diagnosed at age 8 and the risk of persistent rickets: a rare case of pediatric-onset tumor-induced osteomalacia.8岁时诊断出的致癌性佝偻病与持续性佝偻病风险:小儿期肿瘤诱导性骨软化症的罕见病例
Osteoporos Int. 2025 May 13. doi: 10.1007/s00198-025-07469-2.
7
Exploring the Role of FGF7 in Tumor-Induced Osteomalacia. Clinic-Pathologic Analysis in a Patient with a Sino-Nasal Phosphaturic Mesenchymal Tumor.探索FGF7在肿瘤诱导的骨软化症中的作用。一例鼻窦促排磷间叶肿瘤患者的临床病理分析。
Calcif Tissue Int. 2025 Jun 9;116(1):82. doi: 10.1007/s00223-025-01394-6.
8
En bloc resection for treatment of tumor-induced osteomalacia: a case presentation and a systematic review.整块切除治疗肿瘤性骨软化症:病例报告及系统评价
World J Surg Oncol. 2015 May 8;13:176. doi: 10.1186/s12957-015-0589-3.
9
Acquired hypophosphatemic osteomalacia: case series from a Peruvian referral center (1999-2023).获得性低磷性骨软化症:秘鲁转诊中心的病例系列(1999-2023 年)。
Arch Osteoporos. 2024 Nov 19;19(1):116. doi: 10.1007/s11657-024-01476-2.
10
Cystinosis胱氨酸病

本文引用的文献

1
Acquired Osteomalacia Associated with Autoantibodies against PHEX.与抗PHEX自身抗体相关的获得性骨软化症
N Engl J Med. 2025 Jan 30;392(5):513-515. doi: 10.1056/NEJMc2405746.
2
Clinical Applications of Somatostatin Receptor (Agonist) PET Tracers beyond Neuroendocrine Tumors.生长抑素受体(激动剂)PET示踪剂在神经内分泌肿瘤以外的临床应用
Diagnostics (Basel). 2022 Feb 18;12(2):528. doi: 10.3390/diagnostics12020528.
3
Consensus on diagnosis and management of Cushing's disease: a guideline update.库欣病的诊断和治疗共识:指南更新。
Lancet Diabetes Endocrinol. 2021 Dec;9(12):847-875. doi: 10.1016/S2213-8587(21)00235-7. Epub 2021 Oct 20.
4
Diagnosis and Management of Tumor-induced Osteomalacia: Perspectives From Clinical Experience.肿瘤诱导性骨软化症的诊断与管理:临床经验视角
J Endocr Soc. 2021 Jun 2;5(9):bvab099. doi: 10.1210/jendso/bvab099. eCollection 2021 Sep 1.
5
Oncogenic Osteomalacia: An Approach to Diagnosis with a Case Report.致癌性骨软化症:附病例报告的诊断方法
J Clin Diagn Res. 2017 Apr;11(4):ED05-ED07. doi: 10.7860/JCDR/2017/25055.9634. Epub 2017 Apr 1.
6
The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline.库欣综合征的诊断:内分泌学会临床实践指南
J Clin Endocrinol Metab. 2008 May;93(5):1526-40. doi: 10.1210/jc.2008-0125. Epub 2008 Mar 11.